Financial

CardioFocus Secures $55 Million In Financing

MARLBOROUGH, Mass., May 28, 2019 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the completion of a $55 million round of financing. The company’s current syndicate of institutional investors participated in the financing, and included senior debt financing from Kennedy Lewis Investment Management (“Kennedy Lewis“). […]

CathVision Expand Board of Directors

COPENHAGEN, Denmark, May 27, 2019 /PRNewswire/ — CathVision ApS, a medical device company developing, manufacturing and selling cardiac amplifier and electrophysiology products, announced today the addition of two industry leaders to its Board of Directors. Søren Thestrup-Nielsen, MD, was elected Chairman of the Board, and Denis Gestin was elected Member of the Board. Soren Thestrup-Nielsen, […]

Acasti Issues Shares in Settlement of Claims with Former Chief Executive Officer

LAVAL, Québec, May 23, 2019 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) announced that it has completed the previously disclosed issuance of 900,000 common shares from treasury to its former chief executive officer (the “Former CEO”) pursuant to the terms of a settlement agreement […]

Robocath strengthens its medical advisory board with international interventional cardiology experts

Rouen, France, May 21, 2019 – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, announces today that Pr Haude, Dr Lorgat and Pr Nef have joined its medical advisory board. All are global experts and recognized leaders in interventional cardiology. The board […]

Corvidia Therapeutics Announces Dr. Preston Klassen Joins its Board of Directors

WALTHAM, Mass., May 21, 2019 /PRNewswire/ — Corvidia Therapeutics Inc., a clinical stage biotechnology company, today announced the appointment of Dr. Preston Klassen, M.D., M.H.S. to its Board of Directors. Dr. Klassen is presently Executive Vice President, Head of Research and Development at Arena Pharmaceuticals, Inc. (Nasdaq: ARNA). A nephrologist with more than 20 years […]

Dr. Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors

Santa Monica, CA, May 20, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that Dr. Jerome B. Zeldis agreed to re-join the Company as an Independent Director, […]